Tredje AP fonden increased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 43.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 125,959 shares of the healthcare conglomerate’s stock after buying an additional 38,277 shares during the period. UnitedHealth Group comprises approximately 0.8% of Tredje AP fonden’s portfolio, making the stock its 17th largest position. Tredje AP fonden’s holdings in UnitedHealth Group were worth $20,543,000 at the end of the most recent quarter.
Several other institutional investors also recently made changes to their positions in the company. Patriot Financial Group Insurance Agency LLC increased its position in shares of UnitedHealth Group by 1,722.9% in the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock worth $106,000 after buying an additional 603 shares in the last quarter. Cribstone Capital Management LLC increased its position in shares of UnitedHealth Group by 22.6% in the first quarter. Cribstone Capital Management LLC now owns 678 shares of the healthcare conglomerate’s stock worth $113,000 after buying an additional 125 shares in the last quarter. Founders Capital Management acquired a new stake in shares of UnitedHealth Group during the first quarter valued at approximately $135,000. Parkside Financial Bank & Trust boosted its stake in shares of UnitedHealth Group by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock valued at $140,000 after buying an additional 12 shares in the last quarter. Finally, Hanson McClain Inc. boosted its stake in shares of UnitedHealth Group by 1.7% in the first quarter. Hanson McClain Inc. now owns 895 shares of the healthcare conglomerate’s stock valued at $147,000 after buying an additional 15 shares in the last quarter. 86.21% of the stock is owned by institutional investors.
UnitedHealth Group Incorporated (NYSE:UNH) opened at 190.82 on Friday. UnitedHealth Group Incorporated has a 12-month low of $132.39 and a 12-month high of $196.04. The company has a market cap of $184.50 billion, a PE ratio of 22.92 and a beta of 0.64. The stock has a 50 day moving average of $190.49 and a 200-day moving average of $175.87.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.38 by $0.08. The company had revenue of $50.05 billion during the quarter, compared to analyst estimates of $49.97 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. UnitedHealth Group’s revenue was up 7.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.96 earnings per share. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th will be paid a $0.75 dividend. This represents a $3.00 annualized dividend and a yield of 1.57%. The ex-dividend date is Thursday, September 7th. UnitedHealth Group’s dividend payout ratio is currently 35.13%.
TRADEMARK VIOLATION WARNING: This piece of content was first reported by BNB Daily and is the sole property of of BNB Daily. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of United States & international copyright and trademark law. The correct version of this piece of content can be read at https://www.baseball-news-blog.com/2017/08/19/unitedhealth-group-incorporated-unh-stake-boosted-by-tredje-ap-fonden-updated.html.
UNH has been the subject of several analyst reports. Morgan Stanley lifted their price target on shares of UnitedHealth Group from $202.00 to $210.00 and gave the stock an “overweight” rating in a research report on Wednesday, June 28th. Deutsche Bank AG reiterated a “buy” rating and set a $187.00 price target (up previously from $183.00) on shares of UnitedHealth Group in a research report on Saturday, April 22nd. Sanford C. Bernstein reiterated an “outperform” rating and set a $190.00 price target on shares of UnitedHealth Group in a research report on Monday, July 10th. Oppenheimer Holdings, Inc. reiterated an “outperform” rating and set a $205.00 price target (up previously from $203.00) on shares of UnitedHealth Group in a research report on Friday, July 21st. Finally, Zacks Investment Research cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Friday, May 19th. One analyst has rated the stock with a hold rating and twenty-four have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $203.41.
In other UnitedHealth Group news, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction that occurred on Wednesday, June 7th. The stock was sold at an average price of $182.64, for a total value of $913,200.00. Following the completion of the sale, the director now owns 75,735 shares in the company, valued at $13,832,240.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Gail R. Wilensky sold 5,540 shares of the business’s stock in a transaction that occurred on Friday, June 2nd. The shares were sold at an average price of $178.74, for a total value of $990,219.60. Following the completion of the sale, the director now owns 60,516 shares of the company’s stock, valued at approximately $10,816,629.84. The disclosure for this sale can be found here. In the last ninety days, insiders sold 15,540 shares of company stock valued at $2,873,320. 0.89% of the stock is owned by insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.